City to get India's first govt proton therapy unit
Proton therapy—an advanced form of radiation treatment—offers superior tumour control while safeguarding critical organs near the tumour, thus reducing long-term side effects, especially in sensitive areas.
PTI
-
State Minister for Medical Education and Skill Development Sharan Prakash Patil
Bengaluru, 9 June
The State Department of Medical Education
on Monday announced its plan to establish the country’s first government-run
proton therapy facility for cancer treatment at Kidwai Memorial Institute of
Oncology (KMIO).
The move came after State Minister for
Medical Education and Skill Development Sharan Prakash Patil, during a recent
meeting with Union Health Minister JP Nadda in City, submitted a proposal
seeking a Rs 500 crore grant from the Centre to set up this advanced treatment
facility.
Recognised as one of the premier cancer
hospitals in India, KMIO in Bengaluru registers over 21,000 new cancer cases
annually.
Proton therapy—an advanced form of
radiation treatment—offers superior tumour control while safeguarding critical
organs near the tumour, thus reducing long-term side effects, especially in
sensitive areas, an official statement said.
“Unlike conventional radio therapy that
uses high-energy gamma rays or X-rays—which can impact healthy tissues beyond
the tumour—proton therapy delivers precise, targeted doses with significantly
reduced collateral damage,” Patil stated in his proposal.
A statement issued by Patil's office stated
that the proposal highlights the therapy’s benefit in treating paediatric
cancers, especially hereditary types like NF-1 and retinoblastoma, and a wide
range of other malignancies including cancers of the eye, orbit, skull base,
spine, liver, prostate, breast, head and neck, and paranasal sinuses.
It also holds promise for re-irradiation
cases and unresectable tumours, it stated.
"It is estimated that over 1.2 lakh patients in India may require proton therapy by 2025. The facility at KMIO will not only provide cutting-edge cancer care with less toxicity but also support referral cases from NIMHANS and Indira Gandhi Institute of Child Health," Patil added.
Leave a Reply
Your email address will not be published. Required fields are marked *